logo

CARBON FOOTPRINT CERTIFICATE 2023

CARBON FOOTPRINT CERTIFICATE 2023

Leave a Comment / Uncategorized / By

We are very proud to share the results obtained on the reduction of our carbon footprint!

Once again, at Moehs Group, we continue striving and working hard to fulfil our commitment to respect the environment.

In this last calculation of 2023, carried out by Cecot, we have achieved lower emissions compared to the previous period, tracing a very positive annual trend.

In addition, thanks to the photovoltaic panels installed during the second half of 2023, we have managed to emit less CO2:

  • MOEHS IBÉRICA production: 149943 KWh equivalent to 138 Tn of CO2eq not emitted.
  • MOEHS CÁNTABRA production: 180471 KWh equivalent to 131 Tn of CO2eq not emitted.

Thanks to the whole team for making this possible!

 

Leave a Comment

Your email address will not be published. Required fields are marked *

logo
Twitter Linkedin-in
  • Headquarters:
  • Pol. Ind. Cova Solera
  • c/Roma, 8-12 08191 Rubí.
  • Barcelona (Spain)
  • T +34 93 586 05 20
  • Fax +34 93 588 85 13
  • info@moehs.es

Partnering companies

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF A STIMULATOR ACTIVE PRINCIPLE OF SOLUBLE CYCLASE GUANYLATE by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of an active ingredient that stimulates soluble guanylate cyclase.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2024 and they have a financeable budget of €1,862,213.00.
This project is co-financed by the European Union and CDTI.

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF AN ACTIVE INHIBITOR PRINCIPLE OF JANUS KINASE FOR THE TREATMENT OF ATOPIC DERMATITIS.”, by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of a janus kinase inhibitor active ingredient for the treatment of atopic dermatitis.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2025 and they have a financeable budget of €1,940,409.
This project is co-financed by the European Union and CDTI.